Hexylcaine

This classification denotes an anesthetic agent with the molecular formula C16H23NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 511IU0826Z, chemically known as 2-propanol, 1-(cyclohexylamino)-, benzoate (ester) but generally known as hexylcaine, which bears US NIH Compound Identifier 10770. European Medicines Agency schedules Hexylcaine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08043MIG. The term HEXYLCAINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13, No. 12, 1959, List 3). HEXYLCAINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule hexylcaine under HS 29221980 and SITC 51461. As of Q4 2014, HEXYLCAINE remains the US FDA Preferred Term for this commodity. Hexylcaine bears US NLM identifiers UMLS ID C0062686 and NCI Concept Code C65852. SMILES: O(C(CNC1CCCCC1)C)C(=O)C1CCCCC1.